Dapagliflozin Propanediol: Medgend

Dapagliflozin Propanediol FDA Approved Drugs

FARXIGA [Dapagliflozin Propanediol^{C₂₁H₂₅ClO₆C₃H₈O₂H₂O}]

eq 10mg base (oral tablet)

eq 5mg base (oral tablet)

Astrazeneca Ab^{Jan 8, 2014}

Treatment of type 2 diabetes mellitus in a patient, wherein glycemic control (hba1c < 7.0%) is not achievable using one or more of insulin, metformin, pioglitazone, or rosiglitazone.
Treatment of type 2 diabetes mellitus.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

QTERN [Dapagliflozin Propanediol^{C₂₁H₂₅ClO₆C₃H₈O₂H₂O} : Saxagliptin Hydrochloride^{C₁₈H₂₅N₃O₂ClH}]

eq 10mg base : eq 5mg base (oral tablet)

Astrazeneca Ab^{Feb 27, 2017}

Method for treating type 2 diabetes mellitus (t2dm) in patients who are already treated with dapagliflozin and saxagliptin.
Method for treating type 2 diabetes mellitus (t2dm) in patients who have inadequate control with dapagliflozin.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

XIGDUO XR [Dapagliflozin Propanediol^{C₂₁H₂₅ClO₆C₃H₈O₂H₂O} : Metformin Hydrochloride^{C₄H₁₁N₅ClH}]

eq 10mg base : 1gm (oral tablet, extended release)

eq 10mg base : 500mg (oral tablet, extended release)

eq 5mg base : 1gm (oral tablet, extended release)

eq 5mg base : 500mg (oral tablet, extended release)

Astrazeneca Ab^{Oct 29, 2014}

Treatment of type 2 diabetes mellitus in a patient, wherein glycemic control (hba1c < 7.0%) is not achievable using one or more of insulin, metformin, pioglitazone, or rosiglitazone.
Treatment of type 2 diabetes mellitus.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.